![Cover Image for System.Linq.Enumerable+EnumerablePartition`1[System.Char]](https://coverimages.igi-global.com/images/search-article.png)
Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes
LA Lotta, SJ Sharp, S Burgess, JRB Perry, ID Stewart, SM Willems, J Luan, E Ardanaz, L Arriola, B Balkau, H Boeing, P Deloukas, NG Forouhi, PW Franks, S Grioni, R Kaaks, TJ Key, C Navarro, PM Nilsson, K Overvad, D Palli, S Panico, J-R Quirós, E Riboli, O Rolandsson, C Sacerdote, E Salamanca-Fernandez, N Slimani, AMW Spijkerman, A Tjonneland, R Tumino, DL van der A, YT van der Schouw, MI McCarthy, I Barroso, S O'Rahilly, DB Savage, N Sattar, C Langenberg, RA Scott, NJ Wareham
OAI: oai:www.repository.cam.ac.uk:1810/261321 • DOI: 10.17863/CAM.6496
Abstract
ATP Binding Cassette Transporter Subfamily G Member 5 Adult Aged Cholesterol LDL Cohort Studies Coronary Artery Disease Diabetes mellitus Type 2 Drug Therapy Combination Ezetimibe Genetic Association Studies genetic variation Humans Hydroxymethylglutaryl CoA Reductases Hydroxymethylglutaryl-CoA Reductase Inhibitors Lipoproteins Membrane Proteins Membrane Transport Proteins Middle Aged Odds Ratio Polymorphism Genetic Proprotein Convertase 9 Receptors LDL risk Simvastatin